These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18952298)

  • 1. Improved tolerability and quality of life with the new lopinavir/ritonavir tablet formulation.
    Olmo M; Ferrer E; Curto J; Barragán P; Saumoy M; Perulero N; Podzamczer D
    J Infect; 2008 Dec; 57(6):503-5. PubMed ID: 18952298
    [No Abstract]   [Full Text] [Related]  

  • 2. Lopinavir + ritonavir tablets: new formulation. More convenient, but minimal evaluation.
    Prescrire Int; 2007 Aug; 16(90):148. PubMed ID: 17724839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New treatment options for HIV-infected patients].
    Wehr A
    Dtsch Med Wochenschr; 2004 May; 129(19):1093. PubMed ID: 15174468
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-HIV agents. Lopinavir and ritonavir (Kaletra) tablets get tested.
    TreatmentUpdate; 2008 Mar; 20(2):5-6. PubMed ID: 18661644
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection.
    Calza L; Manfredi R; Pocaterra D; Chiodo F
    Int J STD AIDS; 2008 Aug; 19(8):541-4. PubMed ID: 18663041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ritonavir-boosted lopinavir monotherapy due to intolerance to nucleoside reverse transcriptase inhibitors in an HIV-infected paediatric patient].
    Espiau M; Soler-Palacín P; Borrull A; Figueras C
    Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):319. PubMed ID: 21334110
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on: Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children.
    Neely MN; Rakhmanina NY
    J Antimicrob Chemother; 2010 Apr; 65(4):808-9; author reply 809-10. PubMed ID: 20086000
    [No Abstract]   [Full Text] [Related]  

  • 8. The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.
    Chetchotisakd P
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):801-5. PubMed ID: 19735222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lopinavir/ritonavir. (Kaletra).
    Res Initiat Treat Action; 2000 Dec; 6(4):16-8. PubMed ID: 11708169
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of lopinavir in HIV type-1-infected children taking the new tablet formulation once daily.
    van der Flier M; Verweel G; van der Knaap LC; van Jaarsveld P; Driessen GJ; van der Lee M; Hartwig NG; Burger DM
    Antivir Ther; 2008; 13(8):1087-90. PubMed ID: 19195335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stavudine-induced pancreatitis followed by lopinavir-ritonavir-induced pancreatitis: is co-trimoxazole the culprit?
    Bhargava P
    J Postgrad Med; 2008; 54(3):241; author reply 241-2. PubMed ID: 18626183
    [No Abstract]   [Full Text] [Related]  

  • 12. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
    [No Abstract]   [Full Text] [Related]  

  • 13. Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes.
    Prescrire Int; 2009 Jun; 18(101):104. PubMed ID: 19637415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaletra approved in Canada.
    TreatmentUpdate; 2001; 12(11):1-2. PubMed ID: 11570069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of postexposure prophylaxis with the combination of zidovudine-lamivudine and lopinavir-ritonavir for HIV infection.
    Rabaud C; Burty C; Grandidier M; Christian B; Penalba C; Béguinot I; Jeanmaire H; May T
    Clin Infect Dis; 2005 Jan; 40(2):303-5. PubMed ID: 15655751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection.
    Chaubey SK; Sinha AK; Phillips E; Russell DB; Falhammar H
    Sex Health; 2009 Sep; 6(3):254-7. PubMed ID: 19653965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaletra versus nelfinavir.
    TreatmentUpdate; 2001; 12(12):8-10. PubMed ID: 11570097
    [No Abstract]   [Full Text] [Related]  

  • 18. Serious bradyarrhythmia that was possibly induced by lopinavir-ritonavir in 2 patients with acquired immunodeficiency syndrome.
    Kikuchi Y; Genka I; Ishizaki A; Sunagawa K; Yasuoka A; Oka S
    Clin Infect Dis; 2002 Aug; 35(4):488-90. PubMed ID: 12145735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lopinavir/ritonavir dosage form affects quality of life during monotherapy in HIV-positive adults.
    Yeh RF; Lipman BA; Mayberry C; Miguel B; Nemecek JJ; Gathe JC
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):273-7. PubMed ID: 20841439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy.
    Resino S; Palladino C; Lorente R; Micheloud D; Bellón JM; Larru B; Gutiérrez MD; de José MI; Polo R; Muñoz-Fernández MA;
    Pediatr Infect Dis J; 2010 Aug; 29(8):774-7. PubMed ID: 20375850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.